4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-008984
SVP, Chief Accounting Officer sold 1,530 shares at $7.79 ($11,919)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sabatini Brent SVP, Chief Accounting Officer | 2026-02-13 | Sale 10b5-1 | −1,530 | $7.79 | $11,919 | 47,872 | D |
| Open-market sales · 1,530 sh · avg $7.79 · $11,919 | |||||||
Loading xslF345X05/wk-form4_1771447089.xml…